Healx Logo

Healx Blog - Healx

Healx Blog

Interview with Dr Allyson Berent, Chief Scientific Officer at the Foundation for Angelman Syndrome Therapeutics

Following on from our recent announcement that we would be working with the Foundation for Angelman Syndrome Therapeutics (FAST) to find new treatments for Angelman Syndrome, we interviewed Dr Allyson Berent, Chief Scientific Officer at FAST, to learn more about the organisation and the ways in which AI is being used to speed up drug discovery … Continued

Webinar | How to Develop In Vitro Models for Rare Disease Research

In this webinar we explore developing in vitro models for your rare disease research – from both a patient group and industry perspective. Over the course of the 60-minute session our speakers discuss the following topics: 
What makes a good in vitro model The pros and cons of in vitro model system types The use … Continued

Healx teams up with the Foundation for Angelman Syndrome Therapeutics to accelerate novel treatments towards the clinic

Cambridge UK – 12 August 2020 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, is proud to announce its partnership with the Foundation for Angelman Syndrome Therapeutics (FAST) today. This partnership will focus on developing therapies for Angelman syndrome, a rare neurogenetic disorder that affects … Continued

Healx and Muscular Dystrophy UK join forces to find new treatments for rare muscle-wasting diseases

Cambridge UK – 15 July 2020 – Healx, the AI-powered, patient-inspired technology company accelerating the discovery and development of rare disease treatments at scale, today announced its Rare Treatment Accelerator Programme (RTA) partnership with Muscular Dystrophy UK (MDUK). The RTA collaboration will initially focus on finding novel therapies for facioscapulohumeral muscular dystrophy (FSHD) – a … Continued